Home Consultants Mr Mahmoud Elfar

Rutherford Location

Leave a message


  • Urological


Mr Mahmoud Elfar is a Consultant Surgeon specialising in Urology at Rutherford Cancer Centre North West. He was appointed as Urological Surgeon at Liverpool University Hospitals NHSFT in 2011 and received specialised training in urology from Cairo University, which led him to acquire a Masters degree in urology. Following this, he studied to qualify for an MD degree at Queens University Belfast in Prostate Cancer followed by an intensive national training programme in Urology in the UK leading to a Certificate of completion of training.

Mr Mahmoud Elfar also had special training in Minimal Access Surgery / Endourology and in Laparoscopic Renal Surgery (keyhole surgery for both benign and malignant renal conditions) and obtained a degree in laparoscopic surgery from the Universitie De Strasbourg (in France). He has chaired the Urology Cancer Care Quality Group for Merseyside and Cheshire over the past five years, during this time he supported the development of the optimal pathway for prostate cancer, introduced multiparametric MRI as a standard investigation before prostate biopsy and standardised the prostate MRI reporting system. He also ensured each trust had a 'voice' at the clinical reference group and supported patient engagement groups.

Currently, Mr Mahmoud Elfar is continuing his role as a member of the National Institute of Health and Care Excellence Interventional Procedure Committee (NICE IPAC) which he started in December 2017.

Research interests: Prostate cancer, renal stones, renal cancer.


  • Medical School; M.B.Ch, B:Faculty of medicine, Alexandria University, Egypt, Date Obtained: 21 March 1991, Grade: Distinction with Honours
  • Academic Qualifications; MSc (Urology) Cairo University December 1995, MD Queens University Belfast December 2005
  • Professional Qualifications; FRCS (Glasg) March 2000, FRCS (Urol) May 2009, CCT April 2011, Diploma in Laparoscopic Surgery, Strasbourg  February 2012


  • British Association of Urological Surgeons (BAUS)
  • European Association of Urology (EAU)
  • Endo-Urology Society
  • Societe Internationale d’Urologie


1- Assessment of Global methylation in Paraffin Embeded Prostatic Tissues and Cell Lines Using Flow Cytometry. Osama Sharaf Eldin, Mahmoud M. Elfar, Adel Motaal Fouda. Advanced in Medicine and Medical Research 2018; 1(1): 34-38.
2- Mohamed M, Greif PA, Diamond J, Sharafeldin O, Maxwell P, Montironi R, O’Brien A, Young M, Hamilton PW. Changes in chromatin phenotype predict the response to hormonal deprivation therapy in patients with prostate cancer. BJU Int. 2009 Feb;103(3):391-8. Epub 2008 Nov 14.
3- Impact of PCNL technique on patient satisfaction and comparison with uretero-renoscopy for renal stones. Dev Gulur, Tsong Kwong∗,, Shankar Chandrasekhran, Graham Watson, Mahmoud Elfar.International Journal of Surgery; November 2014Volume 12, Supplement 3, Page S107
4- Novel use of air in thulium and holmium laser ablation of bladder transitional cell carcinoma; Dev Gulur, Tsong Kwong, Graham Watson, Mahmoud Elfar. International Journal of Surgery; November 2014Volume 12, Supplement 3, Page S107.
5- How safe is it not to follow up Bosniak 2 cysts?. Tsong Kwong, Dev Gulur, Margerat Lyttle, Suzanne Amin, Shankar Chandrasekhran, Andrew Baird, Mahmoud Elfar. International Journal of Surgery. November 2014Volume 12, Supplement 3, Page S105.
6- Novel ways of tunnelling extra-anatomical urinary diversion stents for obstructed kidneys. B.E. Ayres, M. Elfar, K. Edirisinghe, G.M. Watson. European Urology Journal; September 2011Volume 4, Issue 5, Page 225
8 - Mohamed MA, Greif PA, Diamond J, Sharaf O, Maxwell P, Montironi R, Young RA, Hamilton PW. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int. 2007 Apr;99(4):908-15.
9- M Mohamed, R Montironi, R Nairn, G McCusker, O Sharaf, P Grief, P Maxwell, J Diamond, M Young, R Meddings & PW Hamilton (2005).“Quantitative Bio-imaging of Chromatin organisation, Epigenetic Biomarkers and Chromatin Remodeling enzymes and Response to treatment in prostate cancer patients”. Cellular Oncology, Volume 27, Number 2, Page 25.
10- Mohamed, M., G. Hollins, et al. (2004). “Experience in performing pyelolithotomy and pyeloplasty in children on day-surgery basis.” Urology 64(6): 1220-2; discussion 1222-3.
11- Moahmed M, G Hollins & M Eissa.(2003). “Can Paediatric Renal and Hypospadias surgery be performed on a day-case basis?” BJU International, volume 91 supplement 1, page 87.
12- M Mohamed , C Toland, J Dimond O sharaf, P Maxwell, R Montironi, M Young & P Hamilton (2003). “Epigenetic events and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma”. International Conference on applied Genomics journal, the 9Th ESACP/16th ISDQP meeting issue, page 29.
13- Mohamed M, Hope Y, Nairn R, Craft J, Meddings RN, Al-safar N Gurun M and Al-Mushatat A (2002). “Prognostic Value of p53 and c-erbb-2 in recurrence rate of transitional cell carcinoma of urinary bladder”. BJU International Volume 90 Suppleme


  1. Dr Mahmoud Elfar does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
  2. Dr Mahmoud Elfar does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
  3. Dr Mahmoud Elfar does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.

Get in Touch

If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or

Our Trusted Healthcare Partners